Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-24

Study Completion Date

2018-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A retrospective chart review to assess feeding tolerance in adults who had been switched from an intact protein formula to a peptide-based formula due to feeding intolerance in a complex continuing care facility.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay

NCT02912065

Developmental Disabilities Feeding Disorder

COMPLETED

Nutritional Tolerance and Safety of a Tube Feeding Formula in Children

NCT05838495

Enteral Feeding

COMPLETED NA

Enteral Formula Tolerance of Standard Tube Feedings

NCT02312271

Enteral Feeding

COMPLETED

Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population

NCT01191112

Gastrointestinal Diseases Feeding Intolerance

COMPLETED PHASE3

Retrospective Review of Amino Acid Formula Use at a Children's Center

NCT03497091

Children Requiring Amino Acid-based Formula Tube Feeding Enteral Feeding Intolerance

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Enteral Feeding Intolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enteral tube fed adults

Enteral formula

Enteral Formula

Intervention Type OTHER

Enteral feeding with a peptide-based formula.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enteral Formula

Enteral feeding with a peptide-based formula.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \> 18 years of age on admission to facility
* Prescribed enteral nutrition with the goal to provide at least 90% of estimated daily calorie and protein requirements for ≥ 2 weeks prior to switch
* Received enteral nutrition with an intact protein formula for a minimum of three days prior to a switch to a peptide-based formula
* Have documentation of intolerance to an intact protein formula, followed by a switch in formula received to a peptide-based formula
* Receiving a peptide-based formula formula for ≥ 2 weeks
* Have documentation of an assessment of feeding tolerance following the switch
* Formulas received must be indicated for use in adults.

Exclusion Criteria

* Abdominal surgery (within past 30 days prior to switch)
* Having any infection, including upper respiratory, viral, gastroenteritis,wound infections, c difficile, at time of switch
* Having documented cow's milk protein allergy at time of switch
* Medical records lacking information on rationale for switch to a peptide-based formula and/or response to change (positive, neutral or negative).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No